NEW ORLEANS — Incorporating artificial intelligence into diabetic eye disease testing may increase health equity by giving more patients who are at risk for poor visual outcomes access to screening, according to a poster here.
The retrospective analysis, presented at the Association for Research in Vision and Ophthalmology meeting, compared the characteristics of patients with diabetes who were referred to Wilmer Eye Institute through the standard of care, an eye exam from an ophthalmologist with a referral from a primary care provider, compared with those referred through an autonomous AI system.